Corporate Communications Lead
Spark Therapeutics
Kevin Giordano is the Corporate Communications Lead at Spark Therapeutics. He leads external communications for the gene therapy company that recently received FDA approval of the first gene therapy for a genetic disease in the U.S. Prior to Spark, Kevin spent four years at Bristol-Myers Squibb counseling teams globally on digital and social media and oversaw the company’s social media accounts.
He graduated from Drexel University with a B.S. in Sport Management in 2013. At Drexel, he had internship or part-time experiences with a sports marketing agency managing the brands of professional athletes, Nelligan Sports Marketing at the University of Pennsylvania, the Philadelphia Union and Sky Blue FC in women’s professional soccer.
Kevin is on Twitter: @KevinGiordano